Full Text
Evaluacion De Costo-Utilidad Del Uso De Cetuximab Como Última Línea De Tratamiento Del Cáncer Colorrectal Metastásico

Abstract

Authors

A Croci A Aleman A Perez Galan

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×